MedTrace Logo

The Effect of the Glycemic Variability on Macular Retinal Microcirculation and Cognitive Functions in Patient With Type 1 Diabetes

NCT03821753 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2024-06-10

No results posted yet for this study

Summary

Revadiab is case-control study aimed to demonstrate that retinal capillary density is altered in patients with type 1 diabetes with glycemic variability compared to those with comparable glycemic control without glycemic variability. An OCT angiography will be used to precisely evaluate retinal capillary density.

A secondary objective will be to evaluate if glycemic variability is associated with cognitive dysfunction, using a neuro psychologic evaluation.

Conditions

Interventions

OTHER

Case

* OCT * OCT-Angiography, * Retinophotography * Neuropsychological tests

OTHER

Control

* OCT * OCT-Angiography, * Retinophotography * Neuropsychological tests

Sponsors & Collaborators

  • Délégation de la Recherche Clinique et de l'innovation (DRCI)

    collaborator UNKNOWN

  • CRC (Centre de Recherche Clinique)

    collaborator UNKNOWN

  • SFD (Société Francophone du Diabète)

    collaborator UNKNOWN

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-07
Primary Completion
2021-07-08
Completion
2021-07-08

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03821753 on ClinicalTrials.gov